Bond AmgenX 2.2% ( US031162CM01 ) in USD

Issuer	AmgenX
Market price	100.01 % ▲
Country	United States
ISIN code	US031162CM01 ( in USD )
Interest rate	2.2% per year ( payment 2 times a year)
Maturity	11/05/2020 - Bond has expired
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible
Minimal amount	2 000 USD
Total amount	700 000 000 USD
Cusip	031162CM0
Detailed description	Amgen is a leading biotechnology company focused on developing and delivering innovative therapies for serious illnesses in areas such as oncology, cardiovascular disease, and inflammation. This report details the characteristics of a U.S. dollar-denominated bond, ISIN US031162CM01 (CUSIP: 031162CM0), issued by Amgen, a prominent global biotechnology company headquartered in the United States, known for its focus on discovering, developing, manufacturing, and delivering innovative human therapeutics. The specific debt instrument, with a total issuance size of USD 700,000,000, carried a fixed annual interest rate of 2.2%, disbursed to investors on a semi-annual basis, representing a payment frequency of two times per year. While subject to market fluctuations during its lifetime, the bond was notably observed trading at 100.01% of its par value, indicating strong market perception or demand near its end-of-life cycle; the minimum purchase increment for this security was set at USD 2,000. Crucially, this particular bond reached its full maturity on May 11, 2020, and has subsequently been fully redeemed and repaid to all bondholders, successfully concluding its lifecycle as a debt obligation.